Thus, the upregulation of UBAP2 and OCN in the blood samples from patients with osteoporosis might compensate for elevated bone resorption in postmenopausal osteoporosis (Figs. 6, 7). Here, UBAP2 is linked to postmenopausal osteoporosis.